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The importance of rational prescribing in
low-income and lower-middle-income
countries is highlighted by the paper pub-
lished by Risk and colleagues.1 The
authors evaluated the prescribing practices
of health professionals treating children
under the age of 5 years in 20 different
public health centres in The Gambia.
There were over 300 young children seen
with diarrhoea, and a similar number seen
with an upper respiratory tract infection
(cough and cold only). Approximately half
the children with diarrhoea or an upper
respiratory tract infection received antibio-
tics, and this is clearly inappropriate.
WHO and numerous investigators have
raised concerns regarding the irrational
use of medicines.2 WHO has been instru-
mental in producing an Essential
Medicines List in order to help prescribers
choose the most appropriate medicines.
Additionally, guidelines, both national and
international, have been produced in rela-
tion to the treatment of a variety of
medical conditions. Despite these various
initiatives, WHO has estimated that half of
all medicines are inappropriately pre-
scribed or purchased.2 The rational use of
medicines in children is an area of research
that has been inadequately studied.
It is important, however, that we recog-
nise that rational prescribing for children is
not just an issue for low-income and
lower-middle-income countries. Prescribing
in many high-income countries is often not
rational. One example of this is the vari-
ation in the prescription of antibiotics
between and within different countries.
Children in Italy are four times more likely
to receive antibiotics than children in the
UK, Denmark and The Netherlands.3
Within the UK, as in many other European
countries, newer broad spectrum antibiotics
are being used more extensively. Broad
spectrum antibiotics are more likely to
result in increased antimicrobial resistance.
It is not just antibiotics that are pre-
scribed irrationally. For example, medi-
cines for infants with gastro-oesophageal
reﬂux are now prescribed very extensively,
both in primary care and in hospital, in
the UK. In the vast majority of infants,
gastro-oesophageal reﬂux is a self-limiting
condition. For infants who do require
treatment, thickeners, such as Carobel,
have been shown to be effective. Despite
this, medicines that are more expensive
and more likely to be associated with tox-
icity, such as protein pump inhibitors, are
increasingly being used. This is despite a
systematic review showing that protein
pump inhibitors are ineffective in redu-
cing symptoms associated with gastro-
oesophageal reﬂux in infants.4
Legislation has been introduced in both
Europe and the USA to facilitate clinical
trials in paediatric patients of all ages. The
legislation is to be welcomed if it results
in increased scientiﬁc evidence to enable
health professionals to use medicines
more effectively and safely. This was cer-
tainly the aim of the health professionals
who highlighted the extent of off-label
prescribing in children. It is important to
recognise, however, that health profes-
sionals have a responsibility to use the sci-
entiﬁc evidence that is generated to
prescribe medicines in a rational manner.
The evaluation of whether medicines
are prescribed rationally unfortunately is
difﬁcult. There has been insufﬁcient
research on developing validated tools to
assess prescribing, especially in children.
Quality indicators for outpatient antibiotic
prescribing have been developed by the
European Surveillance of Antimicrobial
Consumption project.5 The majority of
the quality indicators relate to adults, but
three relate speciﬁcally to children. These
three quality indicators suggest that no
more than 20% of children seen in a
clinic with an acute upper respiratory
tract infection, acute tonsillitis or acute
otitis media should be prescribed oral (sys-
temic) antibiotics. It is only through the
development of drug-speciﬁc and disease-
speciﬁc quality indicators for other medi-
cines that one will be able to ensure
children receive the appropriate medicine
whenever they see a health professional.
Before prescribing any medicine,
doctors should always ask themselves the
following questions. First, is there evi-
dence that the medicine is effective in
treating the disease that the patient pre-
sents with and, additionally, is it effective
in the age group of the patient with the
disease? Second, do the beneﬁts of treat-
ment outweigh the risks associated with
the treatment? We all have a responsibility
to our patients to ensure that we use med-
icines that are both safe and effective, but
also that they are used in a rational
manner.
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